The Food and Drug Administration has approved the first nonprescription, “over-the-counter” naloxone nasal spray, Narcan.

Insurtech Oscar Health has named Mark Bertolini as its new chief executive officer, with Bertolini slated to officially take over the role on April 3. 

In a lawsuit filed this week, Ohio Attorney General Dave Yost accused pharmacy benefit managers Express Scripts and Prime Therapeutics of using a little-known, Switzerland-based company to illegally drive up drug prices and ultimately push those higher costs onto patients.